Tech Company Financing Transactions

POINT Biomedical Funding Round

On 8/19/2004, POINT Biomedical raised $27.1 million in funding from De Novo Ventures, Frazier Healthcare Partners and Integra Ventures.

Transaction Overview

Company Information

Company Status

Out of Business

Industry

Biopharmaceutical

Mailing Address

887L Industrial Road
San Carlos, CA 94070
USA

Phone

(650) 596-1400

Website

www.pointbio.com

Email Address

[email protected]

Overview

POINT Biomedical is developing novel technology platforms for imaging and drug delivery applications. The lead product, CARDIOsphere, is an ultrasound-imaging agent for assessing myocardial perfusion, has completed Phase 3 clinical testing in the United States.

Profile

Social Media

Company News

Facebook

YouTube

Management Team

Title

Name

Email & Social

Chief Executive Officer

Tom Feldman

        

Browse more venture capital transactions:

Prev: 8/19/2004: Othera Pharmaceuticals venture capital transaction
Next: 8/23/2004: AngioScore venture capital transaction

Share this article

About Our VC Transactions Data

Our team works diligently to report on every notable VC transaction. VC investment data records reported here are sourced from a variety of public sources. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary